Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial

Abstract

BackgroundProspective studies in non-Mediterranean populations have consistently related increasing nut consumption to lower coronary heart disease mortality. A small protective effect on all-cause and cancer mortality has also been suggested. To examine the association between frequency of nut consumption and mortality in individuals at high cardiovascular risk from Spain, a Mediterranean country with a relatively high average nut intake per person.MethodsWe evaluated 7,216 men and women aged 55 to 80 years randomized to 1 of 3 interventions (Mediterranean diets supplemented with nuts or olive oil and control diet) in the PREDIMED (‘PREvención con DIeta MEDiterránea’) study. Nut consumption was assessed at baseline and mortality was ascertained by medical records and linkage to the National Death Index. Multivariable-adjusted Cox regression and multivariable analyses with generalized estimating equation models were used to assess the association between yearly repeated measurements of nut consumption and mortality.ResultsDuring a median follow-up of 4.8 years, 323 total deaths, 81 cardiovascular deaths and 130 cancer deaths occurred. Nut consumption was associated with a significantly reduced risk of all-cause mortality (P for trend <0.05, all). Compared to non-consumers, subjects consuming nuts >3 servings/week (32% of the cohort) had a 39% lower mortality risk (hazard ratio (HR) 0.61; 95% CI 0.45 to 0.83). A similar protective effect against cardiovascular and cancer mortality was observed. Participants allocated to the Mediterranean diet with nuts group who consumed nuts >3 servings/week at baseline had the lowest total mortality risk (HR 0.37; 95% CI 0.22 to 0.66).ConclusionsIncreased frequency of nut consumption was associated with a significantly reduced risk of mortality in a Mediterranean population at high cardiovascular risk.Please see related commentary: http://www.biomedcentral.com/1741-7015/11/165.Trial registrationClinicaltrials.gov. International Standard Randomized Controlled Trial Number (ISRCTN): 35739639. Registration date: 5 October 2005.

Novel Multimetabolite Prediction of Walnut Consumption by a Urinary Biomarker Model in a Free-Living Population: the PREDIMED Study

“…[1][2][3] Observational studies and clinical trials have reported beneficial effects of nut consumption on chronic diseases and their mediators. [4][5][6] These effects on human health have been attributed to their unique nutritional composition.…”

TRAMP Prostate Tumor Growth Is Slowed by Walnut Diets Through Altered IGF-1 Levels, Energy Pathways, and Cholesterol Metabolism

“…3,4 In addition, these study results also suggest that walnut's beneficial effects with respect to cancer are not lost when walnuts are consumed as part of a typical American diet. More generally, our findings show that the use of total fat content of walnuts specifically or of either a food or a diet when assessing health effects is unwarranted, as it proved a very poor predictor of walnut's health-related effects.…”

“…1,2 The recent PREDIMED human intervention study found that increased nut consumption significantly reduced the risk of all-cause mortality along with reduced risk of cancer mortality, an effect specific to walnuts. 3 Moreover, a recent, large, epidemiological human cohort study found nut consumption had significant inverse associations with total deaths along with those attributable specifically to cancer, heart disease, and respiratory disease. 4 Increasingly, studies using animal models have been used to gain basic insight into the health effects of walnut consumption.…”

Shifting towards a Mediterranean Diet in the US: How Far Do We Have to Go, What Are the Potential Health Benefits and Can We Get There?

“…Additional analyses found that those who ate more than three servings of nuts per week had a 39% reduced risk of early death as compared to those who did not eat nuts [51].…”